| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.006 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |